Analyst picks & changes

Amgen Inc.


Business: Biopharmaceuticals

Cowen & Co. analyst Joyce Lonergan upgraded the Thousand Oaks, Calif., company to "strong buy" with a $100+ year end 1995 price target. She said the company's stock will trade

Read the full 354 word article

How to gain access

Continue reading with a
two-week free trial.